National Heart, Lung, And Blood Institute (nhlbi)
Clinical trials sponsored by National Heart, Lung, And Blood Institute (nhlbi), explained in plain language.
-
Promising drug for Post-Transplant blood issues stalls after single patient
Disease control TerminatedThis study tested a drug called fostamatinib for people who develop low blood cell counts after a stem cell transplant. The goal was to see if the drug could help stabilize red blood cells or platelets without needing transfusions. The study was stopped early after enrolling only…
Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated May 17, 2026 04:41 UTC
-
New Heart-Slicing procedure tested in tiny study
Disease control TerminatedThis study tested a new procedure called SESAME that uses a special wire to slice away extra tissue from the heart wall in people with a condition that blocks blood flow. Only one adult took part before the study was stopped early. The goal was to see if the procedure could be do…
Phase: NA • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated May 08, 2026 12:04 UTC